RESUMEN
D-Amino acid oxidase (DAO) has been established to be involved in the oxidation of D-serine, an allosteric activator of the N-methyl-D-aspartate-type glutamate receptor in the brain, and to be associated with the onset of schizophrenia. The effect of risperidone, a benzisoxazole derivative, atypical antischizophrenic drug, on the activity of human DAO was tested using an in-vitro oxygraph system and rat C6, stable C6 transformant cells overexpressing mouse DAO (designated as C6/DAO) and pig kidney epithelial cells (LLC-PK(1)). Risperidone has a hyperbolic mixed-type inhibition, designated as 'partial uncompetitive inhibition effect', with K(i) value of 41 microM on human DAO. Risperidone exhibited a protective effect from D-amino acid induced cell death in both C6/DAO and LLC-PK(1) cells with 10% increase in viability. These data indicate the involvement of DAO activity in D-serine metabolism and also suggest a new mechanism of action to risperidone as antischizophrenic drug.
Asunto(s)
Antipsicóticos/farmacología , D-Aminoácido Oxidasa/antagonistas & inhibidores , Inhibidores Enzimáticos , Risperidona/farmacología , Esquizofrenia/tratamiento farmacológico , Esquizofrenia/enzimología , Animales , Antipsicóticos/uso terapéutico , Apoenzimas/metabolismo , Apoproteínas/química , Western Blotting , Catálisis , Supervivencia Celular/efectos de los fármacos , Medios de Cultivo , Holoenzimas/metabolismo , Humanos , Cinética , Células LLC-PK1 , Ratones , Ratas , Receptores de N-Metil-D-Aspartato/metabolismo , Proteínas Recombinantes/metabolismo , Risperidona/uso terapéutico , Serina/metabolismo , PorcinosRESUMEN
One of the side effects by interferon ribavirin (I/R) treatment is haemolytic anemia, causing some patients to discontinue I/R treatment. The exact mechanism of I/R-induced anemia is unknown. The aim of this study is to evaluate the effects of I/R treatment on the serum lipid and red blood cell (RBC) membrane lipid profiles of patients with chronic hepatitis C (CHC) and the association between changes of RBC membrane lipids and haemolytic anemia by I/R treatment. Fourteen patients with CHC were treated with I/R and their serum lipid profiles were studied. In addition, in seven of the 14 patients, the RBC membrane lipid profiles were analysed. In the RBC membrane lipid composition, the total cholesterol, total phospholipids and cholesterol/phospholipids (C/PL) ratio were significantly increased. Phosphatidylcholine (PC) and the phosphatidylcholine/ sphingomyelin (PC/SM) ratio were significantly decreased and other phospholipid fractions were significantly increased. Changes in the serum lipids and RBC membrane lipid profiles of patients with CHC treated with I/R were shown. Especially, a decrease in the RBC deformability and membrane fluidity by changes in these RBC membrane lipids was supposed and it is suggested that those changes may result in haemolytic anemia by I/R treatment.
Asunto(s)
Antivirales/efectos adversos , Membrana Eritrocítica/metabolismo , Hepatitis C Crónica/tratamiento farmacológico , Interferón-alfa/efectos adversos , Lípidos/sangre , Lípidos de la Membrana/metabolismo , Ribavirina/efectos adversos , Adulto , Femenino , Hepatitis C Crónica/sangre , Humanos , Masculino , Persona de Mediana Edad , Sustancias Reactivas al Ácido TiobarbitúricoRESUMEN
Eukaryotic promoters often contain a bent DNA structure, suggesting that this structure plays some role in transcription. To reveal the role, we need more information on the promoters that contain or flank a bent DNA structure. In this study, we collected such promoters by the following approach: we first isolated human genomic DNA fragments that contained at least one bent DNA structure, then shotgun cloned them into a promoter trap vector, screened DNA fragments that functioned as a promoter, and finally found the promoters of interest by determining the bent DNA locus and the region expressing promoter activity. From 1,187 recombinant plasmids, we isolated 51 that showed promoter activity. Structural and functional analyses of randomly selected 10 clones with inserts of 548-913 bp demonstrated 11 sequences that could drive transcription. Unexpectedly, all of these clones met our purpose: i.e., each segment that showed a promoter activity (67-179 bp) was very close to the bent DNA structure (spanning about 150 bp in all clones), and in some cases overlapped it. More interestingly, these bent DNA structures all had a superhelical writhe. We propose a hypothesis that in the bent-DNA-containing eukaryotic promoters. bent DNA organizes local chromatin infrastructure appropriately for transcription initiation.
Asunto(s)
ADN/química , Regiones Promotoras Genéticas , Animales , Secuencia de Bases , Cromosomas Humanos Par 1 , Clonación Molecular/métodos , ADN/metabolismo , Desoxirribonucleasas de Localización Especificada Tipo II/metabolismo , Células Eucariotas , Humanos , Biología Molecular/métodos , Datos de Secuencia Molecular , Conformación de Ácido Nucleico , Proteínas Recombinantes/genética , Proteínas Recombinantes/metabolismoRESUMEN
A bent DNA library was constructed from human genomic DNA, from which a new clone belonging to the human LINE-1 sequence family was isolated and characterized. This clone, with a length of 378 base pairs and termed HBC-1 (human bent clone-1), contained an intrinsically occurring curved DNA structure. By permutation analysis, the center of curvature of this fragment was mapped onto the nucleotide position 886 from the 5' terminus of the complete LINE-1 sequence. Reporter plasmids, which contain HBC-1, were effectively integrated into human chromosome, indicating that the bent DNA structure provides a preferential donor site for the integration of human LINE-1 sequences. The present finding may provide an explanation as to why some inactivated LINE-1 sequences on human chromosomes carry the deletion at their 5' termini.
Asunto(s)
ADN/genética , Elementos de Nucleótido Esparcido Largo/genética , Células 3T3 , Animales , Secuencia de Bases , Clonación Molecular , ADN/química , ADN/metabolismo , Enzimas de Restricción del ADN/metabolismo , Electroforesis en Gel de Poliacrilamida , Genoma Humano , Células HeLa , Humanos , Ratones , Datos de Secuencia Molecular , Mutagénesis Insercional , Conformación de Ácido Nucleico , Plásmidos/genética , Alineación de Secuencia , Homología de Secuencia de Ácido Nucleico , TransfecciónAsunto(s)
Hepacivirus/enzimología , Hepacivirus/genética , ARN Polimerasa Dependiente del ARN , Antivirales , Diseño de Fármacos , Genoma Viral , Hepatitis C/tratamiento farmacológico , Conformación Proteica , Estructura Terciaria de Proteína , ARN Polimerasa Dependiente del ARN/química , ARN Polimerasa Dependiente del ARN/fisiología , Proteínas no Estructurales Virales/química , Proteínas no Estructurales Virales/fisiología , Proteínas ViralesRESUMEN
Characteristics of chronic hepatitis C in 99 hemodialysis patients were studied. Eleven out of 18 anti-HCV-positive patients(61.1%) and 13 out of 81 anti-HCV-negative patients (16.0%) were HCV-RNA-positive. Twenty four HCV-RNA-positive patients were divided into 2 groups according to anti-HCV-positivity. Seven out of 11 patients in anti-HCV-positive group and 1 out of 13 in anti-HCV-negative group were infected with more than 100 K copies/ml of HCV. A number of HCV-RNA copy was significantly larger in anti-HCV-positive group. Fourteen biopsies and necropsies in hemodialysis were achieved and the histological diagnosis did not correspond to clinical feature of chronic hepatitis C.
Asunto(s)
Hepatitis C Crónica/epidemiología , Diálisis Renal , Biomarcadores/análisis , Hepacivirus/genética , Anticuerpos contra la Hepatitis C/análisis , Hepatitis C Crónica/diagnóstico , Hepatitis C Crónica/virología , Humanos , ARN Viral/análisisAsunto(s)
Receptores de Superficie Celular , Rodopsina/química , Animales , Bovinos , Cristalización , Proteínas de Unión al GTP/metabolismo , Secuencias Hélice-Giro-Hélice , Conformación Proteica , Receptores de Superficie Celular/química , Receptores de Superficie Celular/fisiología , Rodopsina/fisiología , Transducción de SeñalAsunto(s)
Proteínas de Unión al GTP/metabolismo , Animales , Proteínas de Unión al GTP/química , Proteínas de Unión al GTP/genética , Humanos , Receptores de Superficie Celular/química , Receptores de Superficie Celular/genética , Receptores de Superficie Celular/metabolismo , Rodopsina/química , Rodopsina/genética , Rodopsina/metabolismoRESUMEN
BACKGROUND: It is difficult to control non-resectable locally advanced primary and recurrent breast cancer by conventional modalities. Recently, hyperthermia (HT) has been recognized as an effective adjuvant to radiotherapy (RT) and chemotherapy (CT) in treatment of various malignancies, including breast cancer. PATIENT AND METHODS: The patient was a 58-year-old female Japanese, with breast cancer, T4N2M0, stage IIIb (papillo-tubular carcinoma). Previous treatment included RT and neoadjuvant CT Local HT was performed with a total number of 87 sessions given over 12 months. The mean time of each session was 40 minutes. Elevation of temperature to a tumoricidal level of 43 degrees C was confirmed. The patient received cyclophosphamide (50 mg p.o./day) and tamoxifen (20 mg p.o./day) during the whole period of HT. Due to the decreased amount of WBC, further CT was not possible, except for one course of CMF performed 3 months after the start of HT. RESULTS: The patient had a decrease in the intensity of pain even after the first 3 sessions. In one month, movement in the right shoulder became possible in an anterio-posterior direction. By 5 months, the healing of ulceration became evident. At present, the patient is in continuous CR for 15 months after HT. The movement in the shoulder joint is markedly improved in all directions. In addition, HT did not cause any notable complications. CONCLUSION: Long-term HT may be useful in the management of locally advanced breast cancer and these results should encourage further clinical study.
Asunto(s)
Neoplasias de la Mama/terapia , Hipertermia Inducida/métodos , Neoplasias de la Mama/patología , Femenino , Humanos , Persona de Mediana Edad , Cuidados Paliativos , Factores de TiempoRESUMEN
Vogt-Koyanagi-Harada (VKH) disease is an ocular inflammatory disease and is considered to be a cell-mediated, autoimmune disease against melanocytes. To learn more about the mechanisms involved in VKH disease, the identification of the antigens specific to the disease and the development of an animal model are critically important. We have expressed and purified the melanocyte specific proteins, tyrosinase-related protein 1 (TRP1) and 2 (TRP2). Lewis rats developed an ocular and extraocular inflammatory disease 12 days after immunization with TRP1 or TRP2 that was characterized clinically by the infiltration of inflammatory cells and accumulation of massive fibrin in the anterior and posterior chambers of the eye. Histologically, inflammatory cells were found in the anterior and posterior chambers, iris, ciliary body, the choroid, subretinal space and vitreous body. In severe cases, a serous detachment of the retina was observed. In mild cases, focal inflammatory lesions surrounded by normal chorioretinal architecture were observed and the inflammation persisted for more than 42 days after the injection. Some eyes showed accumulation of epithelioid cells in the choroid or the retinal pigment epithelium which were similar to the Dalen-Fuchs nodules found in patients with VKH disease. The alterations of the photoreceptor outer segment and the outer nuclear layer were less severe than in experimental autoimmune uveitis induced by retinal antigens. Extraocular manifestations such as skin lesions and meningitis were also observed. The clinical course and histological findings in these rats resembled the changes in patients with VKH disease.
Asunto(s)
Inmunización , Monofenol Monooxigenasa/efectos adversos , Síndrome Uveomeningoencefálico/inmunología , Animales , Electroforesis , Electroforesis en Gel de Poliacrilamida , Melanocitos/inmunología , Epitelio Pigmentado Ocular/citología , Epitelio Pigmentado Ocular/inmunología , Ratas , Ratas Endogámicas Lew , Transfección , Úvea/citología , Úvea/inmunología , Síndrome Uveomeningoencefálico/inducido químicamente , Síndrome Uveomeningoencefálico/patologíaRESUMEN
Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) respond to a variety of different external stimuli and activate G proteins. GPCRs share many structural features, including a bundle of seven transmembrane alpha helices connected by six loops of varying lengths. We determined the structure of rhodopsin from diffraction data extending to 2.8 angstroms resolution. The highly organized structure in the extracellular region, including a conserved disulfide bridge, forms a basis for the arrangement of the seven-helix transmembrane motif. The ground-state chromophore, 11-cis-retinal, holds the transmembrane region of the protein in the inactive conformation. Interactions of the chromophore with a cluster of key residues determine the wavelength of the maximum absorption. Changes in these interactions among rhodopsins facilitate color discrimination. Identification of a set of residues that mediate interactions between the transmembrane helices and the cytoplasmic surface, where G-protein activation occurs, also suggests a possible structural change upon photoactivation.
Asunto(s)
Proteínas de Unión al GTP Heterotriméricas/metabolismo , Receptores de Superficie Celular/química , Rodopsina/química , Secuencias de Aminoácidos , Secuencia de Aminoácidos , Animales , Bovinos , Membrana Celular/química , Cristalografía por Rayos X , Enlace de Hidrógeno , Luz , Datos de Secuencia Molecular , Receptores de Superficie Celular/metabolismo , Retinaldehído/química , Retinaldehído/metabolismo , Rodopsina/metabolismo , Bases de Schiff , Estereoisomerismo , Visión OcularRESUMEN
Hematopoietic prostaglandin (PG) D synthase (PGDS) is the first identified vertebrate ortholog in the Sigma class of the glutathione S-transferase (GST) family and catalyzes both isomerization of PGH(2) to PGD(2) and conjugation of glutathione to 1-chloro-2, 4-dinitrobenzene. We introduced site-directed mutations of Tyr(8), Arg(14), Trp(104), Lys(112), Tyr(152), Cys(156), Lys(198), and Leu(199), which are presumed to participate in catalysis or PGH(2) substrate binding based on the crystallographic structure. Mutants were analyzed in terms of structure, GST and PGDS activities, and activation of the glutathione thiol group. Of all the mutants, only Y8F, W104I, K112E, and L199F showed minor but substantial differences in their far-UV circular dichroism spectra from the wild-type enzyme. Y8F, R14K/E, and W104I were completely inactive. C156L/Y selectively lost only PGDS activity. K112E reduced GST activity slightly and PGDS activity markedly, whereas K198E caused a selective decrease in PGDS activity and K(m) for glutathione and PGH(2) in the PGDS reaction. No significant changes were observed in the catalytic activities of Y152F and L199F, although their K(m) for glutathione was increased. Using 5,5'-dithiobis(2-nitrobenzoic acid) as an SH-selective agent, we found that only Y8F and R14E/K did not accelerate the reactivity of the glutathione thiol group under the low reactivity condition of pH 5.0. These results indicate that Lys(112), Cys(156), and Lys(198) are involved in the binding of PGH(2); Trp(104) is critical for structural integrity of the catalytic center for GST and PGDS activities; and Tyr(8) and Arg(14) are essential for activation of the thiol group of glutathione.
Asunto(s)
Células Madre Hematopoyéticas/enzimología , Oxidorreductasas Intramoleculares/genética , Oxidorreductasas Intramoleculares/metabolismo , Aminoácidos/metabolismo , Animales , Arginina/química , Arginina/metabolismo , Catálisis , Dicroismo Circular , Cristalografía por Rayos X , Cartilla de ADN , Dinitrobencenos/farmacología , Escherichia coli/metabolismo , Glutatión/metabolismo , Glutatión Transferasa/metabolismo , Immunoblotting , Inmunohistoquímica , Cinética , Lipocalinas , Modelos Moleculares , Mutagénesis Sitio-Dirigida , Plásmidos/metabolismo , Reacción en Cadena de la Polimerasa , Ratas , Proteínas Recombinantes/metabolismo , Factores de Tiempo , Tirosina/química , Tirosina/metabolismo , Rayos UltravioletaRESUMEN
BACKGROUND: Hepatitis C virus (HCV) is the major etiological agent of hepatocellular carcinoma, and HCV RNA-dependent RNA polymerase (RdRp) is one of the main potential targets for anti-HCV agents. HCV RdRp performs run-off copying replication in an RNA-selective manner for the template-primer duplex and the substrate, but the structural basis of this reaction mechanism has still to be elucidated. RESULTS: The three-dimensional structure of HCV RdRp was determined by X-ray crystallography at 2.5 A resolution. The compact HCV RdRp structure resembles a right hand, but has more complicated fingers and thumb domains than those of the other known polymerases, with a novel alpha-helix-rich subdomain (alpha fingers) as an addition to the fingers domain. The other fingers subdomain (beta fingers) is folded in the same manner as the fingers domain of human immunodeficiency virus (HIV) reverse transcriptase (RT), another RNA-dependent polymerase. The ribose-recognition site of HCV RdRp is constructed of hydrophilic residues, unlike those of DNA polymerases. The C-terminal region of HCV RdRp occupies the putative RNA-duplex-binding cleft. CONCLUSIONS: The structural basis of the RNA selectivity of HCV RdRp was elucidated from its crystal structure. The putative substrate-binding site with a shallow hydrophilic cavity should have ribonucleoside triphosphate (rNTP) as the preferred substrate. We propose that the unique alpha fingers might represent a common structural discriminator of the template-primer duplex that distinguishes between RNA and DNA during the replication of positive single-stranded RNA by viral RdRps. The C-terminal region might exert a regulatory function on the initiation and activity of HCV RdRp.
Asunto(s)
ARN Polimerasas Dirigidas por ADN/química , Hepatitis C/enzimología , Secuencia de Aminoácidos , Cristalografía por Rayos X , ARN Polimerasas Dirigidas por ADN/metabolismo , Modelos Moleculares , Datos de Secuencia Molecular , Conformación Proteica , Homología de Secuencia de Aminoácido , Especificidad por Sustrato , Moldes GenéticosRESUMEN
The clinical and epidemiological studies on TT virus (TTV) were achieved in 44 Japanese HD patients. TTV-DNA was detected in 29.5% of HD patients, and the percentage was higher than that reported in normal populations. HBsAg, anti-HBc, anti-HCV and HGV-RNA were positive in 6.8%, 36.4%, 22.7% and 2.3%, respectively. One of three HD patients with TTV had liver disorders. In comparison between TTV positive and negative groups, there were significant differences of anti-HBc and total cholesterol value.
Asunto(s)
Infecciones por Virus ADN/epidemiología , Virus ADN/aislamiento & purificación , Hepatitis Viral Humana/epidemiología , Diálisis Renal/efectos adversos , Anciano , Biomarcadores/análisis , Infecciones por Virus ADN/virología , ADN Viral/análisis , Femenino , Hepatitis Viral Humana/virología , Humanos , Masculino , Persona de Mediana EdadRESUMEN
BACKGROUND: Simvastatin, a 3-hydroxy 3-methylglutaryl co-enzyme A (HMG-CoA) reductase inhibitor, is used widely for treatment of hypercholesterolemia. Simvastatin may be a suitable treatment for dyslipidemia in hemodialysis (HD) patients. However, investigation of the side-effects and safety of long-term administration of simvastatin to HD patients has been limited. In this study, we investigated the effects and safety of simvastatin and its effects on lipoprotein metabolism in hypercholesterolemic patients on HD. METHODS: Simvastatin was administered at a dosage of 5 mg/day for 24 weeks to 38 HD patients with high serum total cholesterol (TC) levels (200 mg/dl) or low high-density lipoprotein cholesterol (HDL-C) levels (35 mg/dl). Every four weeks, serum lipids, apolipoprotein, lipoprotein (a) [Lp(a)] and malondialdehyde (MDA) levels were measured. In addition, lipid levels were determined in each lipoprotein fraction separated by ultracentrifugation. RESULTS: After 24 weeks of simvastatin administration, TC significantly decreased by 25.7%, and low-density lipoprotein cholesterol (LDL-C) was significantly decreased by 33.6%. Triglyceride (TG) and HDL-C showed no significant changes. Apolipoprotein (apo) B significantly decreased by 24.5% and apo E by 30.0%. No significant changes were observed in the other apolipoproteins. MDA was also significantly decreased, whereas Lp(a) was not significantly altered. In the lipoprotein fractions, very LDL cholesterol (VLDL-C), intermediate-density lipoprotein cholesterol (IDL-C), LDL1 cholesterol (LDL1-C), and LDL2 cholesterol (LDL2-C) showed significant decreases. No particular side-effects were observed during the 12 months of simvastatin administration. CONCLUSIONS: These results suggest that simvastatin appears to be safe and effective in HD patients with hypercholesterolemia.
Asunto(s)
Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Lípidos/sangre , Diálisis Renal , Simvastatina/uso terapéutico , Anciano , Apolipoproteínas B/sangre , Apolipoproteínas B/efectos de los fármacos , Apolipoproteínas E/sangre , Apolipoproteínas E/efectos de los fármacos , Colesterol/sangre , VLDL-Colesterol/sangre , VLDL-Colesterol/efectos de los fármacos , Creatina Quinasa/sangre , Creatina Quinasa/efectos de los fármacos , Femenino , Humanos , Hiperlipidemias/sangre , Hiperlipidemias/tratamiento farmacológico , Fallo Renal Crónico/sangre , Fallo Renal Crónico/terapia , Masculino , Malondialdehído/sangre , Persona de Mediana Edad , Resultado del Tratamiento , Triglicéridos/sangreRESUMEN
Prostaglandin (PG) F synthase catalyzes the reduction of PGD2 to 9alpha,11beta-PGF2 and that of PGH2 to PGF2alpha on the same molecule. PGF synthase has at least two isoforms, the lung-type enzyme (Km value of 120 microM for PGD2 (Watanabe, K., Yoshida, R., Shimizu, T., and Hayaishi, O. (1985) J. Biol. Chem. 260, 7035-7041) and the liver-type one (Km value of 10 microM for PGD2 (Chen, L. -Y., Watanabe, K., and Hayaishi, O. (1992) Arch. Biochem. Biophys. 296, 17-26)). The liver-type enzyme was presently found to consist of a 969-base pair open reading frame coding for a 323-amino acid polypeptide with a Mr of 36,742. Sequence analysis indicated that the bovine liver PGF synthase had 87, 79, 77, and 76% identity with the bovine lung PGF synthase and human liver dihydrodiol dehydrogenase (DD) isozymes DD1, DD2, and DD4, respectively. Moreover, the amino acid sequence of the liver-type PGF synthase was identical with that of bovine liver DD3. The liver-type PGF synthase was expressed in COS-7 cells, and its recombinant enzyme had almost the same properties as the native enzyme. Furthermore, to investigate the nature of catalysis and/or substrate binding of PGF synthase, we constructed and characterized various mutant enzymes as follows: R27E, R91Q, H170C, R223L, K225S, S301R, and N306Y. Although the reductase activities toward PGH2 and phenanthrenequinone (PQ) of almost all mutants were not inactivated, the Km values of R27E, R91Q, H170C, R223L, and N306Y for PGD2 were increased from 15 to 110, 145, 75, 180, and 100 microM, respectively, indicating that Arg27, Arg91, His170, Arg223, and Asn306 are essential to give a low Km value for PGD2 of the liver-type PGF synthase and that these amino acid residues serve in the binding of PGD2. Moreover, the R223L mutant among these seven mutants especially has a profound effect on kcat for PGD2 reduction. The Km values of R223L, K225S, and S301R for PQ were about 2-10-fold lower than the wild-type value, indicating that the amino acid residues at 223, 225 and 301 serve in the binding of PQ to the enzyme. On the other hand, the Km value of H170C for PGH2 was 8-fold lower than that of the wild type, indicating that the amino acid residue at 170 is related to the binding of PGH2 to the enzyme and that Cys170 confer high affinity for PGH2. Additionally, the 5-fold increase in kcat/Km value of the N306Y mutant for PGH2 compared with the wild-type value suggests that the amino acid at 306 plays an important role in catalytic efficiency for PGH2.
Asunto(s)
Hidroxiprostaglandina Deshidrogenasas/genética , Hígado/enzimología , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Northern Blotting , Células COS , Bovinos , Cromatografía en Gel , Clonación Molecular , ADN Complementario , Humanos , Hidroxiprostaglandina Deshidrogenasas/aislamiento & purificación , Hidroxiprostaglandina Deshidrogenasas/metabolismo , Datos de Secuencia Molecular , Mutagénesis Sitio-Dirigida , ARN Mensajero/genética , ARN Mensajero/metabolismo , Proteínas Recombinantes/genética , Proteínas Recombinantes/aislamiento & purificación , Proteínas Recombinantes/metabolismo , Homología de Secuencia de Aminoácido , Especificidad por SustratoRESUMEN
Recombinant plasmids carrying a highly curved DNA structure are sometimes unstable in Escherichia coli. In order to know the underlying mechanism, several plasmids carrying one or two highly bent DNA segment(s) from the human adenovirus type 2 (Ad2) enhancer and/or origin region of phage lambda replication were systematically constructed and propagated in E. coli. The highly bent DNA segments disturbed the action of DNA topoisomerases: i.e. they were shown to be able to produce an anomalously wide spectrum of linking number topoisomers that tails toward lower supercoiling with a little of the DNA actually positively supercoiled. Furthermore, bent DNA caused multimeric plasmid formation. The linking number topoisomers and multimers seemed to be intermediate topological states of the bent DNA-containing plasmids that would lead to the deletion occurring in them. The nucleotide sequence of a deletion product of a bent DNA-containing plasmid showed that the putative source of the severe topological constraint was entirely eliminated from the plasmid.
Asunto(s)
ADN Viral/química , Escherichia coli/genética , Conformación de Ácido Nucleico , Plásmidos/química , Adenovirus Humanos/genética , Bacteriófago lambda/genética , Secuencia de Bases , ADN-Topoisomerasas de Tipo I/metabolismo , ADN Viral/genética , Electroforesis en Gel Bidimensional , Elementos de Facilitación Genéticos , Escherichia coli/crecimiento & desarrollo , Eliminación de Gen , Humanos , Mutación , Plásmidos/genética , Origen de Réplica , Análisis de Secuencia de ADNRESUMEN
AIMS/BACKGROUND: Many epidemiological studies of new hepatitis viruses, including GB virus C (GBV-C) and hepatitis G virus (HGV), have used polymerase chain reaction (PCR) primers designed for the third nonstructural region (NS3R). However, a homology study of GBV-C and HGV genomes revealed that the 5' untranslated region (5'UTR) was more conserved than NS3R. METHODS: We attempted to detect GBV-C/HGV using PCR primers corresponding to the 5' UTR, and compared its incidence to that derived from NS3R primers. Furthermore, PCR products amplified using the 5' UTR primers were sequenced and subjected to phylogenetic analysis. RESULTS: In patients with chronic hepatitis C, the prevalence of GBV-C/HGV by PCR with the NS3R and 5' UTR primers was 5.1% (4/78) and 17.9% (14/78), respectively, and in patients on hemodialysis, it was 0% (0/81) and 5.9% (5/85), respectively. We could not detect GBV-C/HGV in patients with non-A-C liver disease. The incidence of GBV-C/HGV by 5' UTR primers was higher than by NS3R primers. After DNA sequencing at 5' UTR, phylogenetic analysis showed two types of GBV-C/HGV, Jap and HGV types. CONCLUSION: 5' UTR primers proved highly sensitive for detection of GBV-C/HGV and were superior to the NS3R primers.
Asunto(s)
Regiones no Traducidas 5'/genética , Flaviviridae/genética , Hepatitis Viral Humana/diagnóstico , ARN Viral/análisis , Proteínas no Estructurales Virales/genética , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Secuencia de Bases , Cartilla de ADN/química , Femenino , Flaviviridae/aislamiento & purificación , Hepatitis Viral Humana/epidemiología , Humanos , Japón/epidemiología , Masculino , Persona de Mediana Edad , Datos de Secuencia Molecular , Reacción en Cadena de la Polimerasa , Proteínas no Estructurales Virales/aislamiento & purificaciónRESUMEN
Hematopoietic prostaglandin (PG) D synthase is the key enzyme for production of the D and J series of prostanoids in the immune system and mast cells. We isolated a cDNA for the rat enzyme, crystallized the recombinant enzyme, and determined the three-dimensional structure of the enzyme complexed with glutathione at 2.3 A resolution. The enzyme is the first member of the sigma class glutathione S-transferase (GST) from vertebrates and possesses a prominent cleft as the active site, which is never seen among other members of the GST family. The unique 3-D architecture of the cleft leads to the putative substrate binding mode and its catalytic mechanism, responsible for the specific isomerization from PGH2 to PGD2.
Asunto(s)
Oxidorreductasas Intramoleculares , Isomerasas/química , Isomerasas/genética , Animales , Sitios de Unión/fisiología , Clonación Molecular , Cristalografía , ADN Complementario , Epoprostenol/metabolismo , Regulación Enzimológica de la Expresión Génica , Hematopoyesis/fisiología , Isomerasas/metabolismo , Isomerismo , Lipocalinas , Datos de Secuencia Molecular , Prostaglandina D2/química , Prostaglandina D2/metabolismo , Prostaglandina H2 , Prostaglandinas H/química , Prostaglandinas H/metabolismo , Estructura Terciaria de Proteína , ARN Mensajero/metabolismo , Ratas , Ratas Sprague-Dawley , Homología de Secuencia de Aminoácido , Especificidad por Sustrato , Tromboxano A2/metabolismoRESUMEN
Adult male rats were repeatedly treated with ethane dimethanesulfonate (EDS), an agent known to destroy Leydig cells selectively. Following a second injection, changes in serum testosterone levels and histological and morphometric changes of Leydig cells showed the time course to be similar to those after the first treatment. The number and volume of Leydig cells markedly decreased at day 2, began to increase from day 7, and recovered to the values of the control rats at day 30, concomitant with the changes of serum testosterone levels. Cells in the interstitial tissue labeled with bromodeoxyuridine markedly increased in number at day 2, gradually decreased thereafter, and returned to the values of the controls at day 14. During this period, cells undergoing mitosis were seen, their type unable to be determined, but were presumed to be regenerating Leydig cells. Even 30 days following four treatments with intervals of 30 days each, serum testosterone levels were the same as those in the controls. Also the numerical and volume densities of Leydig cells and the volume of an average Leydig cell were the same as those of the controls. Mitosis was observed in mature Leydig cells at this period, if any. It appears that new Leydig cells began to proliferate by division earlier than 14 days after EDS, allowing that there were several stages of proliferation, and that the source of reappearing Leydig cells may not be a limited number of precursor cells, implying the presence of stem cells for Leydig cells.